Validating Simple Modifications to the Rome IV Criteria for the Diagnosis of Irritable Bowel Syndrome in Secondary Care
Alimentary Pharmacology & Therapeutics · 2025-01 · 61 (2) · 354-362
DOI: 10.1111/apt.18363 ↗At a glance
Validierungsstudie in Alimentary Pharmacology & Therapeutics, published online on 2024-10-28. Written by Vivek C Goodoory and 4 co-authors. Institution: Leeds Gastroenterology Institute, St. James's University Hospital, Leeds, UK. Major MEDLINE topics: Irritable Bowel Syndrome, Abdominal Pain, Sensitivity and Specificity, Secondary Health Care. Cited 12 times so far (Crossref); 34 references. The full text is freely available (open access, CC BY 4.0).
Abstract (original language)
Background
The Rome IV criteria for irritable bowel syndrome (IBS) may be too restrictive for clinical practice and research.
Aims
To validate the Rome IV criteria and study the diagnostic performance of simple modifications to them.
Methods
We collected symptom data from consecutive adults with suspected IBS seen in a single clinic. We used a reference standard to confirm IBS (presence of lower abdominal pain associated with altered stool form or frequency; no evidence of organic gastrointestinal disease after limited investigation). We applied Rome IV criteria, but also two modifications. First, we re‐incorporated abdominal discomfort but kept symptom frequency required for both abdominal pain and discomfort to at least 1 day per week. Second, we included only abdominal pain but relaxed symptom frequency back to 3 days per month. We calculated sensitivity, specificity and positive and negative likelihood ratios (LRs), with 95% confidence intervals (CIs), for each diagnostic criterion.
Results
We recruited 170 patients (76.5% female, mean age 37.9 years). Sensitivity and specificity of the Rome IV criteria were 82.1% and 85.1%, respectively; positive and negative LRs were 5.51 (95% CI 2.95–11.3) and 0.21 (95% CI 0.14–0.31), respectively. Modifying the criteria by relaxing the frequency of abdominal pain to 3 days per month led to the best performance [sensitivity 90.2%, specificity 85.1%, positive LR 6.06 (95% CI 3.25–12.2), and negative LR 0.11 (95% CI 0.07–0.19)].
Conclusions
The Rome IV criteria performed well in diagnosing IBS. A simple modification relaxing the required frequency of abdominal pain improved their performance.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Leeds Gastroenterology Institute, St. James's University Hospital, Leeds, UK.
- Leeds Institute for Medical Research at St. James's, University of Leeds, Leeds, UK.
ORCID profiles: Christopher J Black, Alexander C Ford
Cite
APA
Goodoory, V. C., Riggott, C., Khasawneh, M., Black, C. J., & Ford, A. C. (2025). Validating Simple Modifications to the Rome IV Criteria for the Diagnosis of Irritable Bowel Syndrome in Secondary Care. Alimentary Pharmacology & Therapeutics, 61(2), 354-362. https://doi.org/10.1111/apt.18363
Vancouver
Goodoory VC, Riggott C, Khasawneh M, Black CJ, Ford AC. Validating Simple Modifications to the Rome IV Criteria for the Diagnosis of Irritable Bowel Syndrome in Secondary Care. Alimentary Pharmacology & Therapeutics. 2025;61(2):354-362. doi:10.1111/apt.18363
BibTeX
@article{Goodoory2025,
author = {Goodoory, Vivek C and Riggott, Christy and Khasawneh, Mais and Black, Christopher J and Ford, Alexander C},
title = {Validating Simple Modifications to the Rome IV Criteria for the Diagnosis of Irritable Bowel Syndrome in Secondary Care},
journal = {Alimentary Pharmacology & Therapeutics},
year = {2025},
volume = {61},
number = {2},
pages = {354--362},
doi = {10.1111/apt.18363}
}
EUVIMED